10X Genomics target price cut to $55 from $90 by Leerink Partners
TXG•Leerink Partners cut its target price for 10X Genomics to $55 from $90.
Related News
Genpact target price raised to $55 from $45 by Needham
G•
Workers United reports sale of $4.72 million in Amalgamated Financial common shares
AMAL•
SAP research finds AI adoption outpaces workforce readiness at midsize companies
SAP•
Global Partners Q3 revenue climbs 42% on wholesale boost, net profit up 80%
GLP•
60 Degrees Pharmaceuticals secures agreement for exercise of warrants covering 584,492 shares
SXTP•